智通财经APP获悉，CRO概念股集体下跌，截至发稿，金斯瑞生物科技(01548)跌6.05%，报14.92港元；康龙化成(03759)跌4.67%，报20.8港元；维亚生物(01873)跌4.57%，报1.88港元；泰格医药(03347)跌3.71%，报36.9港元。
消息面上，昨晚公布的美国9月非农大超预期，数据公布后，互换合约继续显示美联储12月降息的可能性萎缩。中泰证券认为，2024年以来，海外CPI月度数据虽有波动，但海外有望逐步进入降息节奏，投融资改善预期有望边际向好，且部分公司订单已然看到恢复，该行预计外需CRO/CDMO及国内临床前CRO有望迎来估值修复机会；此外，源于CRO板块受国内外投融资环境、不利因素影响较大，但随着国内政策逐步发力，该行预计板块有望逐步恢复，持续重点关注临床CRO投资机会。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.